Product
Plecanatide
Aliases
Trulance
Name
Trulance
INN Name
Plecanatide
FDA Approved
Yes
3 clinical trials
1 organization
5 indications
1 document
Indication
Chronic ConstipationIndication
Barrett's EsophagusIndication
Gastroesophageal Reflux DiseaseIndication
Neoplasm, Digestive System, MalignantClinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Plecanatide in the Treatment of Functional Constipation in Chinese Patients for up to 12 WeeksStatus: Active (not recruiting), Estimated PCD: 2023-07-13
Clinical trial
A Randomized, Double-blind, Placebo-Controlled, Dose Ranging, Parallel-Group Study of the Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Pilot Study of GCC Agonists to Identify a Cyclic-GMP Signal in Duodenal Tissue of VolunteersStatus: Recruiting, Estimated PCD: 2025-02-01
Document
DailyMed Label: Trulance
Organization
Salix Pharmaceuticals Inc.